HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

AbstractBACKGROUND:
Lipoprotein-associated phospholipase A₂ (Lp-PLA₂) is a recently identified and potentially useful plasma biomarker for cardiovascular and atherosclerotic diseases. However, the correlation between the Lp-PLA₂ activity and carotid atherosclerosis remains poorly investigated in patients with metabolic syndrome (MetS). The present study aimed to evaluate the potential role of Lp-PLA₂ as a comprehensive marker of metabolic syndrome in individuals with and without carotid atherosclerosis.
METHODS:
We documented 118 consecutive patients with MetS and 70 age- and sex-matched healthy subjects served as controls. The patients were further divided into two groups: 39 with carotid plaques and 79 without carotid plaques to elucidate the influence of Lp-PLA₂ on carotid atherosclerosis. The plasma Lp-PLA₂ activity was measured by using ELISA method and carotid intimal-media thickness (IMT) was performed by ultrasound in all participants.
RESULTS:
Lp-PLA₂ activity was significantly increased in MetS subgroups when compared with controls, and was higher in patients with carotid plaques than those without plaques (P < 0.05). Furthermore, we found that significant difference in Lp-PLA₂ was obtained between patients with three and four disorders of metabolic syndrome (P < 0.01). Age (β = 0.183, P = 0.029), LDL-cholesterol (β = 0.401, P = 0.000) and waist-hip ratio (β = 0.410, P = 0.000) emerged as significant and independent determinants of Lp-PLA₂ activity. Multiple stepwise regression analysis revealed that LDL-cholesterol (β = 0.309, P = 0.000), systolic blood pressure (β = 0.322, P = 0.002) and age (β = 0.235, P = 0.007) significantly correlated with max IMT, and Lp-PLA2 was not an independent predictor for carotid IMT.
CONCLUSIONS:
Lp-PLA₂ may be a modulating factor for carotid IMT via age and LDL-cholesterol, not independent predictor in the pathophysiological process of carotid atherosclerosis in patients with MetS.
AuthorsHui-Ping Gong, Yi-Meng Du, Li-Na Zhong, Zhao-Qiang Dong, Xin Wang, Yong-Jun Mao, Qing-Hua Lu
JournalLipids in health and disease (Lipids Health Dis) Vol. 10 Pg. 13 (Jan 19 2011) ISSN: 1476-511X [Electronic] England
PMID21247435 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
Topics
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase (blood)
  • Adult
  • Aged
  • Carotid Arteries (diagnostic imaging, pathology)
  • Carotid Artery Diseases (blood, pathology)
  • Case-Control Studies
  • Enzyme Assays
  • Female
  • Humans
  • Male
  • Metabolic Syndrome (blood, pathology)
  • Middle Aged
  • Risk Factors
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: